Free Trial

Carisma Therapeutics (CARM) Insider Trading & Ownership

Carisma Therapeutics logo
$0.04 +0.00 (+3.99%)
As of 03:58 PM Eastern

Carisma Therapeutics (NASDAQ:CARM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$138.18K
Get CARM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CARM Insider Buying and Selling by Quarter

Carisma Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2025Michael KlichinskyInsiderSell56,982$0.25$14,245.50  
10/3/2025Michael KlichinskyInsiderSell119,347$0.26$31,030.22  
10/2/2025Michael KlichinskyInsiderSell200,000$0.25$50,000.00  
10/1/2025Michael KlichinskyInsiderSell165,000$0.26$42,900.00  
(Data available from 1/1/2013 forward)

CARM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Carisma Therapeutics includes Michael Klichinsky. Learn more on insiders at CARM.

6.90% of Carisma Therapeutics stock is owned by insiders. Learn more on CARM's insider holdings.

The following insider sold CARM shares in the last 24 months: Michael Klichinsky ($138,175.72).

Insiders have sold a total of 541,329 Carisma Therapeutics shares in the last 24 months for a total of $138,175.72 sold.

Ro Khanna (D-CA) has sold shares of Carisma Therapeutics in the last year totaling $8,000.

Carisma Therapeutics Key Executives

  • Mr. Steven Kelly (Age 59)
    President, CEO & Director
    Compensation: $786.91k
  • Mr. Michael Klichinsky Ph.D. (Age 34)
    Pharm.D., PharmD, Co-Founder & Chief Scientific Officer
    Compensation: $525.43k
    4 recent trades
  • Mr. Richard S. Morris CPA (Age 50)
    CFO, Chief Compliance Officer, Treasurer, Prin. Financial Off. & Prin. Acc. Off.
    Compensation: $584.85k
  • Dr. Saar Gill M.D.
    Ph.D., Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Eric H. Siegel J.D. (Age 59)
    MBA, General Counsel & Corporate Secretary
  • Ms. Terry Shields
    Senior Vice President of Human Resources
  • Mr. Tom Wilton (Age 50)
    Chief Business Officer
  • Dr. Eugene P. Kennedy F.A.C.S. (Age 55)
    M.D., Chief Medical Officer
  • Mr. Kenneth Locke
    Senior Vice President of Technical Operations


This page (NASDAQ:CARM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners